In Situ Biologics reported raising $3.95 Million in an initial SEC Form D filing, from an offering of $8 Million
Round Type
Venture
OakdaleManufacturingHealthcareQuick answer
InSitu Biologics raised $3.95 Million in a funding round, dated November 13, 2025. InSitu Biologics is based in Oakdale, Minnesota, United States.
- How much did InSitu Biologics raise?
- InSitu Biologics raised $3.95 Million in a funding round on November 13, 2025.
- What does InSitu Biologics do?
- InSitu Biologics is an emerging biotech company focused on development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection.
- Where is InSitu Biologics based and how big is it?
- InSitu Biologics is based in Oakdale, Minnesota, United States. Fundz records about 8 employees.
- Who are the decision-makers at InSitu Biologics?
- Fundz holds 1 contact at InSitu Biologics, including the Managing Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at InSitu Biologics, and when
A new round usually means InSitu Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day InSitu Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at InSitu Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at InSitu Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment InSitu Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
InSitu Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.